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Serum CRP concentrations are not influenced by age and sex.
2 Serum CRP has shown potential as a prognosticator for survival in some neoplastic conditionssuch as lymphoma, ovarian cancer, thymic cell carcinoma, pancreatic cancer and colorectal cancer. 3 Serum CRP concentration has also been evaluated for monitoring response to therapy and relapse status in dogs with lymphoma.
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Spirocerca lupi ( S. lupi) is a nematode of canidae which commonly infests the esophagus. 4 Dogs become infected when they ingest either the intermediate host or paratenic hosts. Following ingestion, the larvae excyst and eventually reach the caudal thoracic aorta by migrating through the gastric and coelic arteries. From the aorta, the larvae migrate to the caudal thoracic esophagus where they mature into adult worms. 4 In the esophagus, an inflammatory fibrous tissue nodule is formed around the worms. 5 The nodule may be transformed into an osteosarcoma, fibrosarcoma, or anaplastic sarcoma 4 Benign spirocercosis can be successfully treated with doramectin a, at 400µg/kg every two weeks while malignant spirocercosis requires surgical excision of the esophageal sarcoma, with or without chemotherapy, and the long-term prognosis is poor. 6 Ante mortal differentiation between benign and malignant esophageal masses in canine spirocercosis is a diagnostic challenge and is currently based on histopathology of biopsy samples obtained via esophageal endoscopy or surgical excision. However, endoscopically obtained biopsy samples have been 4 shown to be insensitive or non-diagnostic because they often contain only superficial necrotic tissue. 6 Grossly, the benign S. lupi induced nodule has a typical smooth appearance and may sometimes have an operculum through which the female lays its eggs. 6 As the mass enlarges and neoplastic transformation occurs, the mass becomes cauliflower-shaped and lobular with superficial necrosis and ulceration. 6 The endoscopic appearance of the nodule, however, may be misleading since it is subjective and is not 100% accurate. In a few malignant cases, the nodule appeared smooth instead of lobulated and ulcerated as would be expected and the opposite occurred in a small percentage of benign cases.
7
Anemia, leucocytosis, hyperproteinemia and hyperglobulinemia have been associated with neoplastic transformation in canine spirocercosis but all have poor specificity. 8 Reliable, and readily available tests are therefore warranted to help make the distinction. The aims of this study were (1) to determine if serum CRP concentration is elevated in canine spirocercosis, (2) to determine if serum CRP could be used to distinguish between benign and malignant cases and (3) to determine if serum CRP could be used to monitor response to treatment in dogs with benign spirocercosis. The cases were determined to be benign if they had endoscopic visualization of a typical benign nodule at presentation and regression of the nodule in response to doramectin a treatment as observed at f oll ow-up endoscopy at least 6 weeks af ter treatm ent was started. Cases wi th malignant transformation were selected based on histopathology of endoscopically obtained biopsies or entire esophageal masses obtained through surgical excision or at necropsy. All cases had to have serum from the day of presentation that was stored at -80ºC. Analysis of the samples was done as a single batch to avoid inter-assay variation. The data retrieved from the medical records included, age, breed, and bodyweight. Six of the benign cases had follow up serum samples collected between 2 weeks and 4 weeks after treatment was commenced. Twenty one dogs that were presented for routine ovariohysterectomy were included as controls. C-Reactive protein was performed on all the spirocercosis and control cases at presentation. C-reactive protein concentrations were determined as a batch on the stored serum using an automated human CRP Turbidometric Immunoassay b , previously validated for use in dogs.
Materials and methods

Medical
The analysis was performed using an autoanalyser c according to the manufacturer's instructions.
Statistical analysis was performed with SPSS software ±2.6 years) (p=0.12). There were 14 males and 14 females in the benign group of which 12 (86%) of the males and 9 (64%) of the females were intact. There were 7 males and 7 females in the group with malignant spirocercosis of which 4 (57%) of the males and females were intact.
The serum CRP concentration values at presentation had a normal distribution. There was an overall difference in the CRP concentrations of the malignant, benign and control groups. The mean CRP concentration of the benign cases was 60.41 ± 48.02 mg/l (mean ± S.D) l and that of the malignant cases was 76.52 ± 44.79 mg/l both values were significantly higher (p<0.001) than the control group where the mean was 13.39 ± 17.94 mg/l. There was no significant difference in the serum CRP concentrations between malignant and benign cases (p=0.3) (Fig. 1) . Three cases in the malignant group had concurrent benign nodules. Excluding these cases did not change the results of the statistical analysis (data not shown). The mean serum CRP concentration for the six follow-up sera was 1.76 ± 2.8 mg/l compared to 86.96 ± 66.6 mg/l before treatment. The convalescent sera had significantly lower concentrations of CRP compared to the concentrations at presentation (p=0.01) (Fig. 2) .
Discussion
The high serum CRP levels that were observed in the canine spirocercosis cases indicate a marked inflammatory response. Severe inflammation has been described in the histopathology of benign and malignant nodules in canine spirocercosis. 5 The inflammatory reaction in the benign nodule is predominantly lymphoplasmacytic, but pockets of neutrophilic infiltrates around the worms, eggs and migratory tracts are very common. The malignant nodules have a predominantly neutrophilic infiltrate which is associated with areas of ulceration and necrosis. The rapid decrease of CRP concentrations in the absence of continued inflammation makes it an ideal tool for monitoring response to treatment in inflammatory conditions. 9 In this study, six of the benign cases had follow up convalescent sera available for analysis. The CRP levels obtained showed that all six cases had significantly reduced CRP concentrations 2-4 weeks after treatment had been initiated. Follow up endoscopy on the six benign cases correlated well with this result as the nodules were regressing in all cases.
A decrease in serum CRP levels once treatment has commenced is therefore consistent with a positive response to treatment.
C-reactive protein has been shown to have no value in the prognostication of disease outcome as a once off measurement. However, serial CRP measurements have the potential to provide valuable prognostic information. 10 While CRP concentrations at admission in dogs with S. lupi would not be able to differentiate between benign and malignant cases, serial measurements can give valuable prognostic information. Our assumption is that CRP levels will remain elevated in dogs with neoplastic spirocercosis despite treatment because of the ongoing tissue necrosis and ulceration as well as the neoplasia itself. A sustained elevation in serum CRP levels would therefore be likely to be associated with neoplastic transformation and hence carry a poorer prognosis if no other source of inflammation can be identified. A decrease in CRP concentrations The major limitation of this study is the small number of benign cases with follow up serum samples that were available for analysis. In addition, possible concurrent infection and reaction that may continue when a worm is dead may limit the usefulness of CRP. In addition, there was no follow up sera from neoplastic cases available for analysis. C-reactive protein is a nonspecific acute phase protein and as such it is essential to assess patients for concurrent inflammation and or infection which could elevate the CRP. C-reactive protein shows substantial variation between patients. It may be important to establish a baseline for a particular patient at the beginning of treatment in order to have an objective starting point.
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Conclusion
Serum CRP concentration is elevated in both the benign and malignant forms of canine spirocercosis which is a direct reflection of the inflammation observed on histopathology. Single serum CRP measurements cannot, however, be used to differentiate between benign and malignant cases. Serial CRP measurements could potentially be used to differentiate neoplastic from non neoplastic cases and to monitor response to treatment in benign spirocercosis cases in the absence of other causes of an acute phase response.
